# FDA Inspection 1283250 - Saptalis Pharmaceuticals LLC - September 09, 2025

Source: https://www.keypedia.com/records/fda_inspections/saptalis-pharmaceuticals-llc/a4f7cdc9-dc8b-4a3f-b40a-4f847e018bd2
Source feed: FDA_Inspections

> FDA Inspection 1283250 for Saptalis Pharmaceuticals LLC on September 09, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1283250
- Company Name: Saptalis Pharmaceuticals LLC
- Inspection Date: 2025-09-09
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1305912 - 2026-03-06](https://www.keypedia.com/records/fda_inspections/saptalis-pharmaceuticals-llc/110d88c7-f70f-498e-9269-9b842cc13af6)
- [FDA Inspection 1283250 - 2025-09-09](https://www.keypedia.com/records/fda_inspections/saptalis-pharmaceuticals-llc/40933f8b-bc1e-4cd6-aab6-f717cbee79ee)
- [FDA Inspection 1200278 - 2023-03-17](https://www.keypedia.com/records/fda_inspections/saptalis-pharmaceuticals-llc/743fd85a-c506-4838-8be4-90c8775b5a06)
- [FDA Inspection 1046656 - 2018-03-28](https://www.keypedia.com/records/fda_inspections/saptalis-pharmaceuticals-llc/73997aa3-6d42-4162-a8ef-f8f8cf2f3ac0)

Company: https://www.keypedia.com/companies/saptalis-pharmaceuticals-llc/7e9c8055-910b-46e4-9d5a-ee86169bc91d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c